New cancer drug enters human testing for advanced solid tumors
Disease control
Recruiting now
This study is testing a new drug called ASKG915 in people with advanced solid tumors that haven't responded to standard treatments. Researchers want to find the safest and most effective dose, first by giving the drug alone and then by combining it with standard cancer treatments…
Phase: PHASE1, PHASE2 • Sponsor: AskGene Pharma, Inc. • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC